Adjuvant Analgesic Use in the Critically Ill: A Systematic Review and Meta-Analysis - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Critical Care Explorations Année : 2020

Adjuvant Analgesic Use in the Critically Ill: A Systematic Review and Meta-Analysis

Shannon Fernando


This systematic review and meta-analysis addresses the efficacy and safety of nonopioid adjunctive analgesics for patients in the ICU.Data sources: We searched PubMed, Embase, the Cochrane Library, CINAHL Plus, and Web of Science.Study selection: Two independent reviewers screened citations. Eligible studies included randomized controlled trials comparing efficacy and safety of an adjuvant-plus-opioid regimen to opioids alone in adult ICU patients.Data extraction: We conducted duplicate screening of citations and data abstraction.Data synthesis: Of 10,949 initial citations, we identified 34 eligible trials. These trials examined acetaminophen, carbamazepine, clonidine, dexmedetomidine, gabapentin, ketamine, magnesium sulfate, nefopam, nonsteroidal anti-inflammatory drugs (including diclofenac, indomethacin, and ketoprofen), pregabalin, and tramadol as adjunctive analgesics. Use of any adjuvant in addition to an opioid as compared to an opioid alone led to reductions in patient-reported pain scores at 24 hours (standard mean difference, -0.88; 95% CI, -1.29 to -0.47; low certainty) and decreased opioid consumption (in oral morphine equivalents over 24 hr; mean difference, 25.89 mg less; 95% CI, 19.97-31.81 mg less; low certainty). In terms of individual medications, reductions in opioid use were demonstrated with acetaminophen (mean difference, 36.17 mg less; 95% CI, 7.86-64.47 mg less; low certainty), carbamazepine (mean difference, 54.69 mg less; 95% CI, 40.39-to 68.99 mg less; moderate certainty), dexmedetomidine (mean difference, 10.21 mg less; 95% CI, 1.06-19.37 mg less; low certainty), ketamine (mean difference, 36.81 mg less; 95% CI, 27.32-46.30 mg less; low certainty), nefopam (mean difference, 70.89 mg less; 95% CI, 64.46-77.32 mg less; low certainty), nonsteroidal anti-inflammatory drugs (mean difference, 11.07 mg less; 95% CI, 2.7-19.44 mg less; low certainty), and tramadol (mean difference, 22.14 mg less; 95% CI, 6.67-37.61 mg less; moderate certainty).Conclusions: Clinicians should consider using adjunct agents to limit opioid exposure and improve pain scores in critically ill patients.
Fichier principal
Vignette du fichier
cc9-2-e0157.pdf (1.38 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03369878 , version 1 (07-10-2021)


Paternité - Pas d'utilisation commerciale - Pas de modification



Kathleen E Wheeler, Ryan Grilli, John E Centofanti, Janet Martin, Celine Gelinas, et al.. Adjuvant Analgesic Use in the Critically Ill: A Systematic Review and Meta-Analysis. Critical Care Explorations, 2020, 2 (7), pp.e0157. ⟨10.1097/CCE.0000000000000157⟩. ⟨hal-03369878⟩
20 Consultations
86 Téléchargements



Gmail Facebook X LinkedIn More